Davis Polk advised the representatives of the several underwriters in the offering. Akoya Biosciences, Inc. executed its $151.3 million initial public offering of 7,567,000 shares of common...
You must be a Standard 1 Year member to access this content.
Davis Polk advised Jefferies, the sales agent, in the transaction. Beam Therapeutics Inc. executed the at-the-market offering of shares of its common stock for up to a...
You must be a Standard 1 Year member to access this content.
Davis Polk advised Gyroscope Therapeutics Limited on the deal. Gyroscope Therapeutics Limited executed its $148 million private placement of Series C preferred shares. The financing was...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the representative of the initial purchasers in the offering. LD Holdings Group LLC executed its offering of $600 million aggregate principal amount of...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the joint book-running managers in the offering. Solid Biosciences Inc. executed the $143.75 million public offering of common stock. The common stock is listed...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the representative of the initial purchasers in the offering. Shake Shack Inc. executed the offering of $250 million aggregate principal amount of 0%...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the initial purchasers in the offering. Adtalem Escrow Corporation executed the offering of $800 million aggregate principal amount of its 5.50% senior secured...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the placement agent, Jefferies, in the deal. Ayala Pharmaceuticals, Inc. executed its $25 million private placement of common stock and warrants to purchase common...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the joint book-running managers and representatives of the underwriters in the offering. The $62 million initial public offering of 4,427,500 shares of common...
You must be a Standard 1 Year member to access this content.
